Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.86B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
Mercado Libre
MELI
|
+$1.59B |
| 4 |
TSMC
TSM
|
+$1.34B |
| 5 |
Coupang
CPNG
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$2.61B |
| 2 |
EPAM Systems
EPAM
|
+$1.48B |
| 3 |
Twilio
TWLO
|
+$1.35B |
| 4 |
Apple
AAPL
|
+$1.24B |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Healthcare | 9.8% |
| 3 | Financials | 9.16% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
5376
DELISTED
Cymabay Therapeutics
CBAY
| $388K | ﹤0.01% |
124,519
+13,720
| +12% | +$43.2K |
|
5377
AST SpaceMobile
ASTS
$21.4B
| $386K | ﹤0.01% |
38,622
-4,830
| -11% | -$35.5K |
|
5378
CEL-SCI Corp
CVM
$26M
| $386K | ﹤0.01% |
3,282
+558
| +20% | +$90.8K |
|
|
FCO
5379
DELISTED
abrdn Global Income Fund
FCO
| $386K | ﹤0.01% |
62,991
+344
| +0.5% | +$2.33K |
|
|
UXIN
5380
Uxin Ltd
UXIN
$260M
| $386K | ﹤0.01% |
3,781
-2,460
| -39% | -$281K |
|
5381
Clene
CLNN
$53.5M
| $385K | ﹤0.01% |
4,879
+1,515
| +45% | +$91.7K |
|
5382
Nature's Sunshine
NATR
$269M
| $385K | ﹤0.01% |
22,889
-5,315
| -19% | -$94K |
|
5383
Treace Medical Concepts
TMCI
$293M
| $384K | ﹤0.01% |
20,287
-23,998
| -54% | -$466K |
|
|
GAU
5384
Galiano Gold
GAU
$547M
| $383K | ﹤0.01% |
694,184
-94,222
| -12% | -$62.6K |
|
5385
VanEck ChiNext Innovators ETF
CNXT
$111M
| $381K | ﹤0.01% |
9,902
+1,927
| +24% | +$80K |
|
|
NXDR
5386
Nextdoor Holdings
NXDR
$998M
| $381K | ﹤0.01% |
63,562
+54,771
| +623% | +$333K |
|
5387
Innovator US Equity Power Buffer ETF January
PJAN
$1.43B
| $381K | ﹤0.01% |
11,700
| – | – |
|
5388
MVB Financial
MVBF
$397M
| $378K | ﹤0.01% |
9,120
-1,437
| -14% | -$57.7K |
|
|
CANF
5389
Can-Fite BioPharma American Depositary Shares
CANF
$7.28M
| $377K | ﹤0.01% |
1,521
+329
| +28% | +$76K |
|
5390
Lineage Cell Therapeutics
LCTX
$268M
| $376K | ﹤0.01% |
244,155
-284,402
| -54% | -$441K |
|
|
CLLS
5391
Cellectis
CLLS
$296M
| $374K | ﹤0.01% |
82,410
-37,557
| -31% | -$207K |
|
|
SIRE
5392
DELISTED
Sisecam Resources LP
SIRE
| $370K | ﹤0.01% |
19,017
+13,707
| +258% | +$262K |
|
|
PGP
5393
PIMCO Global StockPLUS & Income Fund
PGP
$102M
| $369K | ﹤0.01% |
38,685
+705
| +2% | +$6.91K |
|
5394
Columbus McKinnon
CMCO
$550M
| $368K | ﹤0.01% |
8,685
-14,037
| -62% | -$634K |
|
|
UFOX
5395
Defiance Space and Connective Tech ETF
UFOX
$922M
| $368K | ﹤0.01% |
9,801
+926
| +10% | +$35.2K |
|
5396
Immatics
IMTX
$1.33B
| $365K | ﹤0.01% |
45,637
+947
| +2% | +$8.63K |
|
5397
FlexShares International Quality Dividend Dynamic Index Fund
IQDY
$114M
| $362K | ﹤0.01% |
12,657
+5,356
| +73% | +$157K |
|
5398
Hurco Companies Inc
HURC
$144M
| $360K | ﹤0.01% |
11,427
-11,652
| -50% | -$378K |
|
|
REVG
5399
DELISTED
REV Group
REVG
| $360K | ﹤0.01% |
26,825
-40,094
| -60% | -$547K |
|
5400
Xeris Biopharma Holdings
XERS
$1.52B
| $360K | ﹤0.01% |
140,529
-1,210,258
| -90% | -$2.96M |
|
Similar funds
Morgan Stanley's Q1 2022 Portfolio in Review
As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
- Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
- Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
- Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
- Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
- Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
- Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.